All News

syringe, pill, DMARD, Treatment, therapy

Emerging and exciting treatments in RA: ACR22 preview

Julian Segan, MBBS, BMedSc, FRACP

Rheumatoid arthritis treatment has come leaps and bounds in recent decades. Gone are the days of gold injections, chemical synovectomies, and physician-mandated bedrest (heaven forbid). Though the marketplace for RA treatments is becoming ever more crowded, there are still unmet needs.

Read Article
RA, hands, MCP, deformity

New 2022 EULAR Recommendations for the Management of Rheumatoid Arthritis

Jack Cush, MD

The updated 2022 EULAR recommendations for the management of rheumatoid arthritis (RA) were initially presented by Dr. Josef Smolen at EULAR 2022, and are now in press delineating the most recent developments and perspectives in RA treatment.

Read Article
Convention2.jpg

AS, Lupus and Subclinical RA: What I'm looking forward to at ACR22

Robert Chao, MD

As we approach ACR22, there are many things to be excited about, especially with the reintroduction of in-person attendance. My attention this year is in research being presented in these three areas: ankylosing spondylitis; lupus management and treatment; and, subclinical RA.

Read Article
exercise,group

ACR22 Will Present New Recommendations for Integrative Approach to RA Treatment

ACR

On Sunday Nov. 13, 2022, at ACR Convergence 2022 meeting, the ACR will present a new guideline for Exercise, Rehabilitation, Diet and Additional Integrative Interventions for Rheumatoid Arthritis.

Read Article
Telemedicine

Video Telehealth Willingness Increased During Pandemic

Jack Cush, MD

Americans’ willingness to use video telehealth has increased since the beginning of the COVID-19 pandemic, rising most sharply among Black Americans and people with less education, according to a new RAND Corporation study.

Read Article
Dr. Coldiron (thru case examples) shares how the MSF works in providing medical care to pts in areas of conflict or crisis & how #climate change has also impacted health, including #Mentalhealth #ACR22 @RheumNow @rheumarhyme https://t.co/gFuX4sL0WA
sheila RHEUMarampa ( View Tweet)
50 yo hispanic male +MDA5 Ab w/ synovitis, skin lesions, neg ANA, normal CK, aldolase, +MDA5 Ab, Skin biopsy show changes c/w dermatomyositis. Failed MTX/MMF, no insurance. What is MDA5's role? Does race play a factor in Rx response? What is your next step? @rheumnow #ACR22 https://t.co/tGy2BH6y45
TheDaoIndex KDAO2011 ( View Tweet)
#ClinicalPearl #Methotrexate is recommended for Rx in all EXCEPT…#ACR22 @RheumNow

Janet Pope Janetbirdope ( View Tweet)

Dr. M Tikly share #rheum challenges & solutions in South Africa: 👉⬆️training to gen. practitioners & nurses, 👉estab outreach clinics 👉lobby local government/political groups 👉use of off-label drugs 👉engage pharma: free meds/clinical trials #ACR22 #GlobalHealth @rheumnow https://t.co/BX2qXk1usN
TheDaoIndex KDAO2011 ( View Tweet)
Dr. Tikly discusses the solutions to drug access challenges in South Africa in both state and private sectors 👇 🔸Off label use, buyouts, price⬇️, advocacy... Highly relatable because these are similar challenges we face in the PH @rheumarhyme @doktora_ging #ACR22 @rheumnow https://t.co/ajshylgtIE
sheila RHEUMarampa ( View Tweet)
Finally we're starting to get therapies for polymyalgia rheumatica! The best of PMR therapeutics coming up at #ACR22 (and catch it all @RheumNow): https://t.co/lUPICA3Mim
David Liew drdavidliew ( View Tweet)
#ACR22 Presents New Data on JIA Clinical Remission with Combo DMARDSs New research being presented at #ACR22, demonstrated that polyarticular juvenile idiopathic arthritis patients were more likely to achieve clinical remission with combo DMARDSs. https://t.co/qmfnEvDedA https://t.co/VhkYlZJG3s

Links:

Dr. John Cush RheumNow ( View Tweet)
Dr. Yuz Yusof will be covering #ACR22 as a RheumNow reporter again. He'll be sharing real-time coverage on SLE, auto-inflammatory and COVID. Follow @Yuz6Yusof! https://t.co/3rYlIrM54m
Dr. John Cush RheumNow ( View Tweet)
Follow RheumNow reporter, Dr. Eric Dein, for real-time #ACR22 coverage! https://t.co/NZkVd2A989
Dr. John Cush RheumNow ( View Tweet)
Our newest RheumNow reporter, Dr. Michael Putman , will be covering SLE and Vasculitis at #ACR22 this year. “Looking forward to seeing all my friends and colleagues in person!”-Dr. Putnam Follow him @EBRheum for real-time coverage! https://t.co/DpFa0zwzPX
Dr. John Cush RheumNow ( View Tweet)
#ACR22 Will Present New Recommendations for Integrative Approach to RA Treatment https://t.co/FI5k6LIKrO https://t.co/I0F1wJNBDc

Links:

Dr. John Cush RheumNow ( View Tweet)
We're excited to have Dr. Aurelia Najm back as an #ACR22 RheumNow reporter! "I look forward to learning about developments in the field and finally meet with colleagues and collaborators from all over the world. " -Dr. Najm Follow @AurelieRheumo for real time #ACR22 coverage! https://t.co/o6Mhobt2BR
Dr. John Cush RheumNow ( View Tweet)
Dr. Robert Chao is back as a RheumNow reporter for a third year. "I’m looking forward to the exciting hybrid format of both in person and virtual meeting this year! " Follow @doctorRBC for real-time #ACR22 coverage! https://t.co/j6FNra7aZq
Dr. John Cush RheumNow ( View Tweet)
Join Dr. Jack Cush and Dr. Arthur Kavanaugh as they discuss, dissect and deliberate about data presented at the #ACR22 meeting in Philadelphia. https://t.co/STvWZMS7xS https://t.co/oQt3ZMyjEN

Links:

Dr. John Cush RheumNow ( View Tweet)
2022 EULAR Recommendations for Screening and Prophylaxis of Chronic and Opportunistic Infections A EULAR Task force has developed recommendations for screening and prophylaxis of chronic and opportunistic infections in patients with AIIRD. https://t.co/VrdNggfMfG https://t.co/WARs0YJLZs

Links:

Dr. John Cush RheumNow ( View Tweet)
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×